ATE113213T1 - Gerät zur vorläufigen reperfusionsbehandlung von herzanfallsymptomen. - Google Patents

Gerät zur vorläufigen reperfusionsbehandlung von herzanfallsymptomen.

Info

Publication number
ATE113213T1
ATE113213T1 AT85904048T AT85904048T ATE113213T1 AT E113213 T1 ATE113213 T1 AT E113213T1 AT 85904048 T AT85904048 T AT 85904048T AT 85904048 T AT85904048 T AT 85904048T AT E113213 T1 ATE113213 T1 AT E113213T1
Authority
AT
Austria
Prior art keywords
preliminary
heart attack
reperfusion treatment
attack symptoms
symptoms
Prior art date
Application number
AT85904048T
Other languages
English (en)
Inventor
Stanley Jay Sarnoff
Original Assignee
Survival Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Survival Technology filed Critical Survival Technology
Application granted granted Critical
Publication of ATE113213T1 publication Critical patent/ATE113213T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
    • A61M5/2066—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically comprising means for injection of two or more media, e.g. by mixing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/19—Syringes having more than one chamber, e.g. including a manifold coupling two parallelly aligned syringes through separate channels to a common discharge assembly

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • External Artificial Organs (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Surgical Instruments (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thermotherapy And Cooling Therapy Devices (AREA)
  • Farming Of Fish And Shellfish (AREA)
  • Medicinal Preparation (AREA)
AT85904048T 1984-08-08 1985-08-08 Gerät zur vorläufigen reperfusionsbehandlung von herzanfallsymptomen. ATE113213T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/638,695 US4658830A (en) 1984-08-08 1984-08-08 Method and apparatus for initiating reperfusion treatment by an unattended individual undergoing heart attack symptoms

Publications (1)

Publication Number Publication Date
ATE113213T1 true ATE113213T1 (de) 1994-11-15

Family

ID=24561055

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85904048T ATE113213T1 (de) 1984-08-08 1985-08-08 Gerät zur vorläufigen reperfusionsbehandlung von herzanfallsymptomen.

Country Status (9)

Country Link
US (3) US4658830A (de)
EP (1) EP0192667B1 (de)
JP (4) JPS61502893A (de)
AT (1) ATE113213T1 (de)
AU (1) AU586830B2 (de)
CA (1) CA1265009A (de)
DE (1) DE3587941T2 (de)
IL (1) IL76119A (de)
WO (1) WO1986001118A1 (de)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4658830A (en) * 1984-08-08 1987-04-21 Survival Technology, Inc. Method and apparatus for initiating reperfusion treatment by an unattended individual undergoing heart attack symptoms
US4795433A (en) * 1985-05-20 1989-01-03 Survival Technology, Inc. Automatic injector for emergency treatment
US4832682A (en) * 1984-08-08 1989-05-23 Survival Technology, Inc. Injection method and apparatus with electrical blood absorbing stimulation
US5275812A (en) * 1985-06-07 1994-01-04 The General Hospital Corporation Method of treatment for myocardial infarction
US4839170A (en) * 1985-10-01 1989-06-13 Survival Technology, Inc. Protein absorption enhancing agents
US4889134A (en) * 1988-03-25 1989-12-26 Survival Technology, Inc. Device for measuring multiple channels of heartbeat activity and encoding into a form suitable for simultaneous transmission over
US4862896A (en) * 1988-03-25 1989-09-05 Survival Technology, Inc. Monitoring device with dual position electrodes
US5770198A (en) * 1988-05-18 1998-06-23 The Research Foundation Of The State Of New York Platelet-specific chimeric 7E3 immunoglobulin
US5270198A (en) * 1988-05-20 1993-12-14 Genentech, Inc. DNA molecules encoding variants of tissue plasminogen activators, vectors, and host cells
US5342616A (en) * 1988-06-20 1994-08-30 The Wellcome Foundation Limited Method of administering tissue plasminogen activator
US5262170A (en) * 1988-09-02 1993-11-16 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties and substituted at amino acid positions 296-299, DNA molecules encoding them, vectors, and host cells
US5714145A (en) * 1988-09-02 1998-02-03 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
EP0432431B1 (de) * 1989-11-16 1993-06-16 PHIDEA S.p.A. Flüssige Arzneimittel zur nasalen Anwendung, die ein Polypeptid als Wirksubstanz enthalten
US5571786A (en) * 1990-08-16 1996-11-05 Immuno Aktiengesellschaft Use of protein C or the activation peptide of protein C for preparing a pharmaceutical preparation
US5264420A (en) * 1990-09-27 1993-11-23 Merck & Co., Inc. Fibrinogen receptor antagonists
EP0519210B1 (de) * 1991-06-10 1996-02-28 International Business Machines Corporation Einziehbarer faseroptischer Stecker für Computer
US5415167A (en) * 1992-01-10 1995-05-16 Wilk; Peter J. Medical system and associated method for automatic diagnosis and treatment
PT786257E (pt) * 1992-06-03 2003-12-31 Genentech Inc Variantes de glicosilacao do activador de plasminogenio tissular com propriedades terapeuticas meloradas
US5339823A (en) * 1992-08-07 1994-08-23 Survival Technology, Inc. Twelve-lead portable heart monitor and method
US5465727A (en) * 1994-08-26 1995-11-14 Brunswick Biomedical Corporation Twelve-lead portable heart monitor
US5912261A (en) * 1994-12-20 1999-06-15 Nippon Zoki Pharmaceutical Co., Ltd. Carboxyalkyl heterocyclic derivatives
US6197806B1 (en) 1995-12-20 2001-03-06 Nippon Zoki Pharmaceutical Co., Ltd. Eliminating agent for activated oxygen and free radicals
JPH10182460A (ja) * 1996-12-27 1998-07-07 Nippon Zoki Pharmaceut Co Ltd ３−デオキシグルコソン生成阻害剤
AU754989B2 (en) 1998-11-16 2002-11-28 Nippon Zoki Pharmaceutical Co., Ltd. A therapeutic agent for intractable vasculitis
US6112116A (en) * 1999-02-22 2000-08-29 Cathco, Inc. Implantable responsive system for sensing and treating acute myocardial infarction
US6272379B1 (en) 1999-03-17 2001-08-07 Cathco, Inc. Implantable electronic system with acute myocardial infarction detection and patient warning capabilities
EP1075847A1 (de) * 1999-08-13 2001-02-14 Walter A. Strunz Autoinjektion zur Vermeidung eines Herzinfarkts
JP4711523B2 (ja) 2001-02-13 2011-06-29 日本臓器製薬株式会社 低アルブミン血症改善剤
ES2182698B1 (es) * 2001-05-14 2004-09-16 Consejo Superior De Investigaciones Cientificas Procedimiento para la extraccion cuantitativa de gluten en alimentos procesados o no procesados por calor, y composicion solubilizante de proteinas de gluten o un kit comercial que la contenga necesarios para su puesta en practica.
US6468263B1 (en) 2001-05-21 2002-10-22 Angel Medical Systems, Inc. Implantable responsive system for sensing and treating acute myocardial infarction and for treating stroke
DE10133216B4 (de) * 2001-07-09 2005-01-27 Tecpharma Licensing Ag Positionsdetektion
US6959216B2 (en) * 2001-09-27 2005-10-25 University Of Connecticut Electronic muscle pump
US20030176797A1 (en) * 2002-03-12 2003-09-18 Fernando Anzellini Thrombust; implantable delivery system sensible to self diagnosis of acute myocardial infarction for thrombolysis in the first minutes of chest pain
US20040039337A1 (en) * 2002-08-21 2004-02-26 Letzing Michael Alexander Portable safety auto-injector
US7801596B2 (en) 2002-09-20 2010-09-21 Angel Medical Systems, Inc. Physician's programmer for implantable devices having cardiac diagnostic and patient alerting capabilities
US20040168951A1 (en) * 2003-02-27 2004-09-02 Mackie Robert W. Method and system for self administration of medications
IL157981A (en) 2003-09-17 2014-01-30 Elcam Medical Agricultural Cooperative Ass Ltd Auto injector
US20050113886A1 (en) * 2003-11-24 2005-05-26 Fischell David R. Implantable medical system with long range telemetry
IL160891A0 (en) 2004-03-16 2004-08-31 Auto-mix needle
US7794713B2 (en) 2004-04-07 2010-09-14 Lpath, Inc. Compositions and methods for the treatment and prevention of hyperproliferative diseases
US7621891B2 (en) * 2004-12-06 2009-11-24 Washington Biotech Corporation Method and apparatus for delivering epinephrine
US20060129122A1 (en) * 2004-12-06 2006-06-15 Wyrick Ronald E Method and apparatus for delivering epinephrine
US7297136B2 (en) * 2004-12-06 2007-11-20 Wyrick Ronald E Medicine injection devices and methods
US7905352B2 (en) * 2004-12-06 2011-03-15 Washington Biotech Corporation Kits containing medicine injection devices and containers
US20110226646A1 (en) * 2004-12-06 2011-09-22 Wyrick Ronald E Kits Containing Medicine Injection Devices And Containers
EP1904145A2 (de) * 2005-07-06 2008-04-02 Washington Biotech Corp. Verfahren und gerät zur abgabe von epinephrin
US20070016089A1 (en) * 2005-07-15 2007-01-18 Fischell David R Implantable device for vital signs monitoring
US8838215B2 (en) * 2006-03-01 2014-09-16 Angel Medical Systems, Inc. Systems and methods of medical monitoring according to patient state
US20090074720A1 (en) * 2005-10-28 2009-03-19 Sabbadini Roger A Methods for decreasing immune response and treating immune conditions
US20080213274A1 (en) * 2005-10-28 2008-09-04 Sabbadini Roger A Compositions and methods for the treatment and prevention of fibrotic, inflammatory, and neovascularization conditions of the eye
US8781566B2 (en) * 2006-03-01 2014-07-15 Angel Medical Systems, Inc. System and methods for sliding-scale cardiac event detection
US8002701B2 (en) 2006-03-10 2011-08-23 Angel Medical Systems, Inc. Medical alarm and communication system and methods
US7862812B2 (en) * 2006-05-31 2011-01-04 Lpath, Inc. Methods for decreasing immune response and treating immune conditions
US20080014550A1 (en) * 2006-07-13 2008-01-17 Henry Schein, Inc. Dental handpiece performance sensor
US8366682B2 (en) 2009-03-04 2013-02-05 Washington Biotech Corporation Medicine injection apparatuses
WO2016101069A1 (en) * 2014-12-23 2016-06-30 Atkinson Cole Michael Joseph Multiple needle assembly
WO2018107690A1 (zh) 2016-12-15 2018-06-21 深圳瑞健生命科学研究院有限公司 一种预防和治疗肥胖症的方法
JP7168990B2 (ja) 2016-12-15 2022-11-10 タレンゲン インターナショナル リミテッド 肥満症を予防および治療するための方法および薬物
CN108210915A (zh) * 2016-12-15 2018-06-29 深圳瑞健生命科学研究院有限公司 改善心脏病变的药物及其用途
SG11201908128YA (en) 2017-03-15 2019-10-30 Idorsia Pharmaceuticals Ltd Subcutaneous administration of a p2y12 receptor antagonist

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3391695A (en) * 1966-06-17 1968-07-09 Stanley J. Sarnoff Cartridge with reflexed burstable diaphragm
US3572336A (en) * 1968-04-30 1971-03-23 Daniel R Hershberg Syringe
US3910260A (en) * 1972-03-01 1975-10-07 Survival Technology Method and apparatus of treating heart attack patients prior to the establishment of qualified direct contact personal care
US3792700A (en) * 1972-03-01 1974-02-19 Survival Technology Apparatus and method of monitoring the electrical activity of the heart of a human with armpit located electrodes
US4004577A (en) * 1972-12-04 1977-01-25 Survival Technology, Inc. Method of treating heart attack patients prior to the establishment of qualified direct contact personal care
US3882863A (en) * 1973-08-01 1975-05-13 Survival Technology Hypodermic injection device having cannula covered with resilient sheath
US3938507A (en) * 1973-11-01 1976-02-17 Survival Technology Incorporated Portable heart monitor
US4153689A (en) * 1975-06-13 1979-05-08 Takeda Chemical Industries, Ltd. Stable insulin preparation for nasal administration
GB1527605A (en) * 1975-08-20 1978-10-04 Takeda Chemical Industries Ltd Insulin preparation for intranasal administration
US4226235A (en) * 1979-01-25 1980-10-07 Survival Technology, Inc. Plural injecting device
US4329988A (en) * 1980-12-23 1982-05-18 Survival Technology, Inc. Plural injection assembly
US4394863A (en) * 1981-10-23 1983-07-26 Survival Technology, Inc. Automatic injector with cartridge having separate sequentially injectable medicaments
US4658830A (en) * 1984-08-08 1987-04-21 Survival Technology, Inc. Method and apparatus for initiating reperfusion treatment by an unattended individual undergoing heart attack symptoms
US4661469A (en) * 1984-08-08 1987-04-28 Survival Technology, Inc. t-PA composition capable of being absorbed into the blood stream and method of administration

Also Published As

Publication number Publication date
IL76119A0 (en) 1985-12-31
JPS61502895A (ja) 1986-12-11
DE3587941T2 (de) 1995-02-23
USRE32919E (en) 1989-05-09
EP0192667A1 (de) 1986-09-03
AU586830B2 (en) 1989-07-27
WO1986001118A1 (en) 1986-02-27
JPS61502892A (ja) 1986-12-11
US4658830A (en) 1987-04-21
IL76119A (en) 1990-07-12
CA1265009A (en) 1990-01-30
JPS61502869A (ja) 1986-12-11
AU4722785A (en) 1986-03-07
JPH069610B2 (ja) 1994-02-09
DE3587941D1 (de) 1994-12-01
US4772585A (en) 1988-09-20
EP0192667A4 (de) 1988-02-01
EP0192667B1 (de) 1994-10-26
JPS61502893A (ja) 1986-12-11

Similar Documents

Publication Publication Date Title
ATE113213T1 (de) Gerät zur vorläufigen reperfusionsbehandlung von herzanfallsymptomen.
DE3687741D1 (de) Geraet zur ultraschallechographie der bewegung von koerperorganen, insbesondere der blutstroemung oder des herzens.
LU90710I2 (fr) Galanthamine ou ses sels d'addition acides
SE9401406D0 (sv) Pharmaceutical products for curing tumourous diseases and process for preparing same
ATE80039T1 (de) Pharmazeutische zusammensetzung, enthaltend 2',3'-dideoxycytidin-2'-en(2',3'-dideoxy-2',3'didehydrocytidin) zur behandlung von mit retrovirus infizierten patienten.
DK325289A (da) Strontiumsalt, fremgangsmaade til fremstilling heraf samt farmaceutiske midler indeholdende saltet
ES8704962A1 (es) Un procedimiento para preparar 1b-d-ribofuranosil, 1-2-4-triazol-3-carboxamida.
ATE61522T1 (de) Pharmazeutische zubereitung zur behandlung von tinea pedis.
HUT41632A (en) Process for preparing agents for the enhancement of protein absorption
ZA849576B (en) 1,7-diphenyl-3-methyllaza-7-cyano-8-methylnonane for use in the treatment of diseases
DE3650368D1 (de) Verwendung von Depogen zur Behandlung von eingeschränktem Blutkreislauf.
IL76121A0 (en) Protein absorption enhancing agents
DK277387D0 (da) Terapeutisk topikal sammensaetning mod en hyperprolifererende epithelsygdom
ATE79550T1 (de) Die proteinabsorption verbessernde stoffe.
FI885025A0 (fi) Koagulationshaemmande protein pp4-x, dess framstaellning och anvaendning.
FI843695A7 (fi) Insuliini-johdannaisia, joissa B 30-asema on modifioitu, menetelmiä niiden valmistamiseksi ja niiden käyttö sekä sokeritaudin hoitoon tarkoitettuja lääkeaineita.
SU589583A1 (ru) Способ определени нарушени функциональной способности почек
EP0210099A3 (en) Use of n-(1-allyl-2-pyrrolidinylmethyl)-2-methoxy-4-amino-5-methylsulfamoylbenzamide in the treatment of parkinsons's disease
FI871737A0 (fi) Kraftanlaeggning med foerbraenning i en fluidiserad baedd.
RU94007838A (ru) Способ лечения геморрагической лихорадки с почечным синдромом
ATE74767T1 (de) Arzneimittelzusammensetzung zur behandlung des lungenverstopfens.
RU94005179A (ru) Средство для лечения больных очаговой склеродермией
NO884654L (no) Virusantigen, fremgangsmaate for dets fremstilling og anvendelse i diagnose og terapi (vaksine).
ATE28403T1 (de) Vorrichtung zur thermotherapiebehandlung durch inhalieren.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties